A Study of JZP150 in Adults With Posttraumatic Stress Disorder
Trial details
- Registry ID
- NCT05178316
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of JZP150 in Adults With Posttraumatic Stress DisorderNCT05178316 | Jazz Pharmaceuticals | Phase 2 | Completed | 2023-12-05Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |